International Journal Of Modern
Pharmaceutical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Science & Pharmacy Professional

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

INTERNATIONAL JOURNAL OF MODERN PHARMACEUTICAL RESEARCH has been indexed and abstracted by various international reputed agencies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , Web of Science Group (Under Process) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , IP Indexing (IP Value 2.42) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing (ISI) , Scope Database , ABCD Index , Academia  and many more.
ISSN 2319-5878
IMPACT FACTOR: 6.669

Abstract

INVESTIGATION OF APOPTOTIC AND ANGIOGENİC EFFECTS OF BORON IN HUMAN LUNG CANCER CELLS (A549)

Hande Aytuğ* and Funda Karabağ Çoban

ABSTRACT

Today, lung cancer, one of the most important health problems, is the most common cause of mortality in both men and women. A549 lung cells derived from human alveolar carcinoma cells match the type II alveolar cell phenotype, have many characteristics of human primary alveolar epithelial cells. Boron is used in many fields such as , nuclear, glass, ceramics, pharmaceuticals, detergents, agriculture and its usage areas are increasing day by day. Recent studies have shown that boron is an important element for human health. Based on this information, this study investigated the effect of different concentrations of boric acid in the A549 human lung cancer cell line, by analyzing proliferation assay, TAS (Total Antioxidant Status), TOS (Total Oxidant Status), VEGF (Vascular Endothelial Growth Factor) and PARP (Poly (ADP-). Ribose Polymerase). Proliferation assay was performed using CCK8 Assay Kit. TAS, TOS, VEGF and PARP analyzes were performed using Sun-Red Human Total Antioxidant Status Elisa Kit, Sun-Red Human Total Oxidant Status Elisa Kit, Sun-Red Human (VEGF) Elisa Kit and Sun-Red Human (PARP) Elisa Kit, respectively. it is made. In the study, the proliferation test showed that the viability values decreased in proportions with doses at 5 mM, 10 mM, 20 mM, 40 mM and 100 mM concentrations and the IC50 value was determined as 20 mM. There was no significant difference between TAS and TOS analysis. In VEGF values, it was observed that VEGF values decreased at 10 mM and 20 mM boric acid concentrations compared to the control group, but there was no significant difference in 40 mM boric acid concentration. A significant increase in PARP values was observed at all concentrations of 10 mM, 20 mM and 40 mM. As a result; We may be think 10 mM, 20 mM and 40 mM concentrations of boric acid may decrease angiogenesis by decreasing VEGF levels. As a result of the increase in PARP values, we may be think boric acid leads to cell necrosis at concentrations of 10 mM, 20 mM and 40 mM.

[Full Text Article] [Certificate Download]

Indexing

News

  • Call for Paper

    IJMPR  Invited to submit your valuable manuscripts for Coming Issue.

  • IJMPR: MAY ISSUE PUBLISHED

    MAY 2024 Issue has been successfully launched IJMPR on 1 MAY 2024.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • IJMPR: New Impact Factor

    IJMPR Impact Factor has been Increased to 6.669 for Year 2024.

  • NEW ISSUE PUBLISHED

    Its Our pleasure to inform you that, IJMPR 1 May 2023 Issue has been Published, Kindly check it on https://ijmpronline.com/current-issues

Best Paper Awards

IJMPR is awarding one article from each issue as "BEST PAPER AWARD", Winner will get a "Certificate of Appreciation" along with cash reward. The best paper of the issue is as follows :

Best Article of current issue

Download Article : Click here

Powered By IJMPR | All Right Reserved

IJMPR